Skip to content

Medical emergency? What to do

Europeans get unequal cancer care -Swedish study

3-RXPublished January 18, 20092 min read

Key points

  • European patients continue to receive unequal access to cancer treatment depending on where they live, according to new findings from experts at Sweden's Karolinska Institute published on Friday.
  • Their analysis reveals wide gaps in relative survival rates across Europe, reflecting differing levels of access to modern - and expensive - cancer treatments.
  • Overall, patients in Austria, France and Switzerland have the broadest access to newer cancer treatments, while Poland, the Czech Republic and Britain lag behind.
  • "For patients and society this is a real concern, as expectations are that all patients in Europe should have equal opportunity to access these treatments, particularly when evidence shows that access to cancer treatment is linked to an improvement in outcome."

European patients continue to receive unequal access to cancer treatment depending on where they live, according to new findings from experts at Sweden's Karolinska Institute published on Friday.

The latest research by Nils Wilking, a clinical oncologist, and Bengt Jonsson, a health economist, updates earlier work undertaken by the two cancer specialists in 2005 and 2007.

Their analysis reveals wide gaps in relative survival rates across Europe, reflecting differing levels of access to modern - and expensive - cancer treatments.

In Sweden, for example, 60.3 percent of men and 61.7 percent of women diagnosed with cancer survive compared with only 37.7 percent of men and 49.3 percent of women in the Czech Republic.

Overall, patients in Austria, France and Switzerland have the broadest access to newer cancer treatments, while Poland, the Czech Republic and Britain lag behind.

"The inequalities - highlighted in our original report in 2005 - still remain," Jonsson said in a statement.

"For patients and society this is a real concern, as expectations are that all patients in Europe should have equal opportunity to access these treatments, particularly when evidence shows that access to cancer treatment is linked to an improvement in outcome."

The research was supported by an unrestricted grant from European drugmakers, which have long campaigned against curbs on access to expensive new cancer drugs in Europe.

Cancer is the fastest-growing section of the drugs market but the use of pricey medicines - like Avastin and Erbitux from Roche and Merck KGaA - is restricted in some European countries, where state-backed healthcare systems are struggling with escalating costs.

LONDON (Reuters)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.